Literature DB >> 3410877

Analysis of metastatic competence of mouse bladder carcinoma cells after transfection with activated Ha-ras or N-ras oncogenes.

J Pohl1, A Radler-Pohl, L M Franks, V Schirrmacher.   

Abstract

Transfection of the Ha-ras oncogene into a low metastatic epithelial cell line resulted in the acquirement of significantly increased metastatic capacity. This alteration in metastatic competence of a carcinoma line in a syngeneic system seemed to be a selective change and was not affected by parameters such as tumor latency period or local tumor growth. Transfection of the selection marker vectors with normal cellular DNA or with the N-ras gene did not lead to significantly increased metastatic capacity. Analysis of metastatic variants after oncogene transfection and in vivo selection showed integration of N-ras, but not of Ha-ras oncogenes. A possible role for the Ha-ras oncogene in the initial steps of metastasis will be discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3410877     DOI: 10.1007/bf02128181

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.

Authors:  L Sistonen; J Keski-Oja; I Ulmanen; E Hölttä; B J Wikgren; K Alitalo
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

4.  The ability of normal mouse cells to reduce the malignant potential of transformed mouse bladder epithelial cells depends on their somatic origin.

Authors:  J K Cowell; L M Franks
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

5.  Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.

Authors:  R J Muschel; J E Williams; D R Lowy; L A Liotta
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

6.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver metastases of human colon carcinoma.

Authors:  A Radler-Pohl; J Pohl; V Schirrmacher
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

8.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.

Authors:  A P Feinberg; B Vogelstein; M J Droller; S B Baylin; B D Nelkin
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

10.  Use of gene transfer and a novel cosmid rescue strategy to isolate transforming sequences.

Authors:  G Brady; A Funk; J Mattern; G Schütz; R Brown
Journal:  EMBO J       Date:  1985-10       Impact factor: 11.598

View more
  4 in total

1.  Induction of the metastatic phenotype by transfection of the nuclear oncogene p53: increases in cytoplasmic diacylglycerol levels and reduction in class I major histocompatibility antigen expression are not sufficient to explain the changes in metastatic capacities.

Authors:  J Pohl; V Lehmann; A Radler-Pohl; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.

Authors:  G Brunner; J Pohl; L J Erkell; A Radler-Pohl; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.

Authors:  M Ballin; A R Mackay; J L Hartzler; A Nason; M D Pelina; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

Review 4.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Authors:  J E Testa; J P Quigley
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.